DORIS TAN: Open Payments
NPI 1578522462 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 53 payments from 8 companies in 2025. Trend: 2023 $562 · 2024 $767 · 2025 $1,424
Food & beverage: $1,313Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $391 |
| Alkermes, Inc. | 11 | $274 |
| Otsuka America Pharmaceutical, Inc. | 8 | $197 |
| Vanda Pharmaceuticals Inc. | 4 | $176 |
| Neurocrine BioSciences, Inc. | 16 | $165 |
| E.R. Squibb & Sons, L.L.C. | 4 | $159 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: AUSTEDO XR, INGREZZA, FANAPT, COBENFY, LYBALVI, ARISTADA, ABILIFY MAINTENA, UZEDY.
Industry payments across CA — which companies pay providers there.
